These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27032980)

  • 1. Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.
    Davis BA; Nagarajan A; Forrest LR; Singh SK
    Sci Rep; 2016 Apr; 6():23789. PubMed ID: 27032980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding.
    Esendir E; Burtscher V; Coleman JA; Zhu R; Gouaux E; Freissmuth M; Sandtner W
    J Biol Chem; 2021 Jul; 297(1):100863. PubMed ID: 34118233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.
    Larsen MB; Sonders MS; Mortensen OV; Larson GA; Zahniser NR; Amara SG
    J Neurosci; 2011 Apr; 31(17):6605-15. PubMed ID: 21525301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.
    Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K
    ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.
    Coleman JA; Yang D; Zhao Z; Wen PC; Yoshioka C; Tajkhorshid E; Gouaux E
    Nature; 2019 May; 569(7754):141-145. PubMed ID: 31019304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and structural investigation of the paroxetine-human serotonin transporter complex.
    Coleman JA; Navratna V; Antermite D; Yang D; Bull JA; Gouaux E
    Elife; 2020 Jul; 9():. PubMed ID: 32618269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative drug binding conformations of monoamine transporters.
    Ravna AW; Sylte I; Kristiansen K; Dahl SG
    Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
    J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray structures and mechanism of the human serotonin transporter.
    Coleman JA; Green EM; Gouaux E
    Nature; 2016 Apr; 532(7599):334-9. PubMed ID: 27049939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
    Nencetti S; Mazzoni MR; Ortore G; Lapucci A; Giuntini J; Orlandini E; Banti I; Nuti E; Lucacchini A; Giannaccini G; Rossello A
    Eur J Med Chem; 2011 Mar; 46(3):825-34. PubMed ID: 21272963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium/calmodulin-dependent kinase II regulates the interaction between the serotonin transporter and syntaxin 1A.
    Ciccone MA; Timmons M; Phillips A; Quick MW
    Neuropharmacology; 2008 Oct; 55(5):763-70. PubMed ID: 18602929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism.
    Apparsundaram S; Stockdale DJ; Henningsen RA; Milla ME; Martin RS
    J Pharmacol Exp Ther; 2008 Dec; 327(3):982-90. PubMed ID: 18801947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.
    Abramyan AM; Slack RD; Meena S; Davis BA; Newman AH; Singh SK; Shi L
    Neuropharmacology; 2019 Dec; 161():107411. PubMed ID: 30391505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
    Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
    ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel.
    Galli A; Petersen CI; deBlaquiere M; Blakely RD; DeFelice LJ
    J Neurosci; 1997 May; 17(10):3401-11. PubMed ID: 9133366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW; Sylte I; Dahl SG
    J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.
    Gabrielsen M; Kurczab R; Ravna AW; Kufareva I; Abagyan R; Chilmonczyk Z; Bojarski AJ; Sylte I
    Eur J Med Chem; 2012 Jan; 47(1):24-37. PubMed ID: 22071255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.